ArticleScience advances2019

A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.

Erdem Bangi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.